Document is current
Any future updates will be listed below
-
Authors
Bredel, Delphine
Tihic, Edi
Mouraud, Séverine
Danlos, François-Xavier
Susini, Sandrine
Aglave, Marine
Alfaro, Alexia
Mohamed-Djalim, Chifaou
Rouanne, Mathieu
Halse, Héloise
Bigorgne, Amélie
Tselikas, Lambros
Dalle, Stéphane
Hartl, Dana M.
Baudin, Eric
Guettier, Catherine
Vibert, Eric
Rosmorduc, Olivier
Robert, Caroline
Ferlicot, Sophie
Parier, Bastien
Albiges, Laurence
de Montpreville, Vincent Thomas
Besse, Benjamin
Mercier, Olaf
Even, Caroline
Breuskin, Ingrid
Classe, Marion
Radulescu, Camélia
Lebret, Thierry
Pautier, Patricia
Gouy, Sébastien
Scoazec, Jean-Yves
Zitvogel, Laurence
Marabelle, Aurélien http://orcid.org/0000-0002-5816-3019
Bonvalet, Mélodie
- License Information
-
More Information
Article History
Received: 14 July 2023
Accepted: 11 November 2023
First Online: 6 December 2023
Declarations
:
: This non-interventional research project not involving the human person complies with the French methodology reference MR-003 governing the processing of health data of public interest, carried out in the context of research involving the human person and for which all patients concerned have been informed in writing, and did not object to participating after having been informed (Deliberation no. 2018–154 of 3 May 2018; JORF no. 0160 of 13 July 2018; Text no. 109).
: This project was funded by the Fondation MSD Avenir (ExternalRef removed). Gustave Roussy received funding for running industry sponsored clinical trials from companies developing antibodies against most of the immune checkpoints described in this manuscript: Roche/Genentech, Tesaro/GSK, BMS, Pfizer, Novartis, Medimmune/Astra Zeneca, Sanofi, Eli Lilly, Innate Pharma, Merck (MSD), Merck Serono, Symphogen/Servier. AM has been an investigator of clinical trials and/or has provided expertise through consulting and scientific advisory boards for Roche/Genentech, GSK, BMS, Pfizer, Novartis, Medimmune/Astra Zeneca, Sanofi, Eli Lilly, Innate Pharma, Merck (MSD), Merck Serono, Symphogen/Servier.
